全文获取类型
收费全文 | 2186篇 |
免费 | 161篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 97篇 |
妇产科学 | 13篇 |
基础医学 | 247篇 |
口腔科学 | 31篇 |
临床医学 | 230篇 |
内科学 | 428篇 |
皮肤病学 | 25篇 |
神经病学 | 192篇 |
特种医学 | 107篇 |
外科学 | 159篇 |
综合类 | 23篇 |
一般理论 | 2篇 |
预防医学 | 428篇 |
眼科学 | 34篇 |
药学 | 236篇 |
中国医学 | 2篇 |
肿瘤学 | 88篇 |
出版年
2023年 | 11篇 |
2022年 | 30篇 |
2021年 | 51篇 |
2020年 | 35篇 |
2019年 | 42篇 |
2018年 | 67篇 |
2017年 | 48篇 |
2016年 | 45篇 |
2015年 | 47篇 |
2014年 | 82篇 |
2013年 | 89篇 |
2012年 | 139篇 |
2011年 | 109篇 |
2010年 | 79篇 |
2009年 | 90篇 |
2008年 | 100篇 |
2007年 | 125篇 |
2006年 | 117篇 |
2005年 | 98篇 |
2004年 | 83篇 |
2003年 | 56篇 |
2002年 | 75篇 |
2001年 | 66篇 |
2000年 | 83篇 |
1999年 | 64篇 |
1998年 | 47篇 |
1997年 | 32篇 |
1996年 | 30篇 |
1995年 | 28篇 |
1994年 | 27篇 |
1993年 | 29篇 |
1992年 | 36篇 |
1991年 | 42篇 |
1990年 | 29篇 |
1989年 | 30篇 |
1988年 | 30篇 |
1987年 | 29篇 |
1986年 | 19篇 |
1985年 | 27篇 |
1984年 | 15篇 |
1983年 | 6篇 |
1982年 | 7篇 |
1981年 | 7篇 |
1980年 | 6篇 |
1979年 | 7篇 |
1978年 | 5篇 |
1977年 | 4篇 |
1975年 | 4篇 |
1972年 | 3篇 |
1970年 | 3篇 |
排序方式: 共有2354条查询结果,搜索用时 46 毫秒
1.
2.
3.
4.
5.
6.
青蒿琥酯皮肤擦剂在小鼠和兔体内的药代动力学研究 总被引:1,自引:0,他引:1
将青蒿琥酯溶于苯二甲酸二甲酯,加适量氨酮制成皮肤擦剂。给兔脱毛后,皮肤涂抹此擦剂25mg/kg后,血药浓度达峰时间平均为2 h,峰浓度平均为1.80μg/ml。药物在兔体内平均驻留时间为3.54 h,清除半衰期约为2.46 h。给小鼠脱毛皮肤涂抹擦剂6.7,31.3和71.4 mg/kg,血药浓度在给药后0.5~4 h达高峰,峰浓度分别为0.82,2.05和7.11μg/ml,体内药物平均驻留时间为3.39,2.79及3.54 h,清除半衰期为2.35,1.93及2.45 h。可见,给兔及小鼠皮肤擦剂后,青蒿琥酯吸收良好,血药浓度维持时间较长。 相似文献
7.
Anthony M Dart Jan Erik Otterstad Bridget-Anne Kirwan John D Parker Sophie de Brouwer Philip A Poole-Wilson Jacobus Lubsen 《European journal of echocardiography》2007,8(4):275-283
AIMS: To evaluate the relationship between echocardiographic cardiac function and outcome in patients with stable symptomatic angina. METHODS: Baseline echo left ventricular ejection fraction and volume data measured in a central laboratory was available for 7016 patients (92% of the total) participating in the ACTION trial (A Coronary disease Trial Investigating Outcome with Nifedipine GITS). Ejection fraction was also measured by investigators. Evaluation of the different echocardiographic variables was based on adjusted hazard ratios comparing the unfavourable limit of the 90% range of the variable concerned to the favourable limit. RESULTS: The centrally measured ejection fraction was the most powerful predictor of all-cause death (adjusted hazard ratio=2.5), myocardial infarction, any stroke or transient ischaemic attack and overt heart failure (adjusted hazard ratio=4.5). The addition of either end systolic volume or end diastolic volume to ejection fraction did not materially affect the power of prediction. Compared to the central ejection fraction measurement, the investigator-measured ejection fraction was a less powerful predictor for all outcomes considered. CONCLUSION: Routine echocardiography carefully analysed by standardised methods provides useful prognostic information in patients with stable angina, including for total mortality. 相似文献
8.
Brenda D. Jamerson Pharm.D. George E. Dukes Pharm.D. Kim L.R. Brouwer Pharm.D. Ph.D. Karl H. Dorm Ph.D. John A. Messenheimer M.D. J. Robert Powell Pharm.D. 《Pharmacotherapy》1994,14(1):47-52
Study Objective . To compare the frequency, severity, and time course of venous irritation after administration of a single intravenous dose of phenytoin with an equimolar dose of fosphenytoin, a water-soluble phenytoin prodrug. Design . Randomized, double-blind, two-period, crossover study. Setting . University hospital clinical research unit. Patients . Twelve healthy volunteers within 15% of ideal body weight and with no clinically significant abnormalities on physical examination, medical history, or laboratory assessment. Interventions . Volunteers randomly received a 30-minute infusion of phenytoin sodium 250 mg (250 mg/5 ml) or an equimolar dose of fosphenytoin 375 mg (375 mg/5 ml). Subjects returned for the crossover treatment 14–21 days later. Measurements and Main Results . Subjects assessed venous irritation (pain, burning, itching), and investigators evaluated phlebitis (erythema, swelling, tenderness), induration, exudation, and cording. Phenytoin was associated with a significantly higher degree of pain at the infusion site in all subjects and a significant degree of phlebitis in eight subjects (p<0.05); cording occurred in six subjects. The time course of phenytoin-induced phlebitis was bimodal. Erythema and tenderness were prominent at the end of the infusion and again at 24 hours. Cording was first noted between 24 hours and 1 week after infusion. In contrast, fosphenytoin was associated with mild pain in two subjects, one incident of phlebitis, and no erythema or cording. Conclusions . Fosphenytoin administration resulted in significantly less venous irritation and phlebitis compared with an equimolar dose of phenytoin. The clinical use of this water-soluble phenytoin prodrug should minimize the frequency and severity of infusion-site reactions and should allow convenient, rapid, intravenous administration of drug, undiluted or admixed with intravenous solutions. 相似文献
9.